Skip to main content
TipRanks
Go Ultimate75% OFF

John B Sanfilippo & Son (JO1) AI Stock Analysis

0 Followers
DE:JO1

John B Sanfilippo & Son

(Frankfurt:JO1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative balance sheetLow leverage gives JBSS meaningful financial resilience while preserving capacity to fund operations and strategic investments. Solid returns on equity indicate that the company continues to generate productive earnings from its capital base, despite recent profitability pressure.
Negative Factors
Revenue and margin pressureLower sales and gross margin show that pricing, product mix, and operating-cost pressures are currently weakening earnings quality. If this persists, reduced profitability could limit internally funded investment and make the benefits of new capacity slower to appear.

John B Sanfilippo & Son (JO1) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%50%DE:JO1-7.50%EWG+6.38%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 664.19M
Dividend Yield
7.61%
Average Volume (3M)
373
Price to Earnings (P/E)
11.8
Beta (1Y)
0.19
Revenue Growth
-1.97%
EPS Growth
-19.26%
Country
Germany
Employees
1,770
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

John B Sanfilippo & Son Business Overview & Revenue Model

Company Description

John B. Sanfilippo & Son, Inc., operating across the United States through its subsidiary JBSS Ventures, LLC, specializes in the processing and distribution of both tree nuts and peanuts. The company's core offerings include a wide selection of raw a...

John B Sanfilippo & Son Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q1-2027)|% Change Since:-15.56%|Next Earnings Date:Feb 03, 2027
Earnings Call SentimentNeutral

The call presented a mixed outlook. The company reported stable overall volume, strong recipe nut and contract manufacturing growth, distribution gains, lower borrowing costs, and validated long-term opportunities in protein-forward bars and private-label products. However, these positives were offset by declines in sales, gross profit, gross margin, net income, EPS, consumer-channel volume, snack nuts and trail mix, and private-label bars, along with continued inflation, pricing, competitive, and demand-planning challenges.

Positive Updates

Stable Volume and Sequential Profitability Improvement
Sales volume was unchanged from the prior-year period, marking the third consecutive quarter of stable or improving volume performance. Diluted EPS improved by more than 50% versus the fourth quarter of fiscal 2026.

Negative Updates

Net Sales Declined 3.5%
First-quarter net sales decreased 3.5% to $288.1 million from $298.7 million in the prior-year quarter. The decrease was due to a 3.6% decline in weighted average selling price per pound, primarily attributable to product mix shifting toward lower-priced items and lower selling prices for walnuts, trail and snack mix products, and peanuts.

Company Guidance

Looking ahead to the remainder of fiscal 2027, the company expects to replace a significant portion of the lost consumer volume with incremental contract manufacturing volume, although this shift will result in a less favorable sales mix; pricing actions go into effect either early January or early February, depending on the customer, but the gross margin impact has not yet been calculated; the new contract manufacturing customer had approximately 7.9 million pounds of volume in Q1, and the company expects that number to maintain and grow the next several quarters; benefits from high-speed fruit and grain, high-speed chewy, and the protein line are expected in Q4, with protein-bar customer shipments beginning at the end of Q4 and Q1; the commercialized bar line should be fairly well optimized within three to six months, while the fruit and grain line is expected to be fully optimized sometime late Q4; and the company’s current projection for absorbing costs and inefficiencies is about three to five years.

John B Sanfilippo & Son Risk Analysis

John B Sanfilippo & Son disclosed 25 risk factors in its most recent earnings report. John B Sanfilippo & Son reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

John B Sanfilippo & Son Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:JO1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SJMSJM64Neutral$14.27B61.894.06%3.32%5.08%―
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
HRLHRL58Neutral$12.22B34.844.33%5.33%0.73%-54.64%
SMPLSMPL50Neutral$1.08B-7.39-10.23%―-6.51%-266.08%
BGSBGS44Neutral$216.19M-3.50-20.97%15.53%-2.67%66.94%
UTZUTZ43Neutral$2.05B-33.31-5.53%1.77%0.48%-739.44%

* Consumer Defensive Sector Average

Performance Comparison

-40%-20%0%20%40%DE:JO1BGSHRLSJMSMPLUTZDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:JO1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:JO1John B. Sanfilippo & Son49.40-4.95-9.11%
BGSB&G Foods3.67-0.30-7.60%
HRLHormel Foods Corp21.950.482.24%
SJMJ.M. Smucker Company133.0727.1325.61%
SMPLThe Simply Good Foods Company12.64-6.93-35.41%
UTZUtz Brands Inc14.254.1440.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.